• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microbiol Immunol . Suitability of NIID-MDCK cells as a substrate for cell-based influenza vaccine development from the perspective of adventitious

tetano

Editor, Senior Moderator
Microbiol Immunol


. 2022 May 11.
doi: 10.1111/1348-0421.12985. Online ahead of print.
Suitability of NIID-MDCK cells as a substrate for cell-based influenza vaccine development from the perspective of adventitious virus susceptibility


Itsuki Hamamoto[SUP] 1 [/SUP], Hitoshi Takahashi[SUP] 1 [/SUP], Noriko Shimazaki[SUP] 1 [/SUP], Kazuya Nakamura[SUP] 1 [/SUP], Katsumi Mizuta[SUP] 2 [/SUP], Ko Sato[SUP] 3 [/SUP], Hidekazu Nishimura[SUP] 3 [/SUP], Norio Yamamoto[SUP] 1 4 [/SUP], Hideki Hasegawa[SUP] 1 [/SUP], Takato Odagiri[SUP] 1 [/SUP], Masato Tashiro[SUP] 1 [/SUP], Eri Nobusawa[SUP] 1 [/SUP]



Affiliations

Abstract

The practical use of cell-based seasonal influenza vaccines is currently being considered in Japan. From the perspective of adventitious virus contamination, we assessed the suitability of NIID-MDCK cells (NIID-MDCK-Cs) as a safe substrate for the isolation of influenza viruses from clinical specimens. We first established a sensitive multiplex real-time PCR system to screen for 27 respiratory viruses and used it on 34 virus samples that were isolated by passaging influenza-positive clinical specimens in NIID-MDCK-Cs. Incidentally, the limit of detection of the system was 100 or fewer genome copies per reaction. In addition to influenza viruses, human enterovirus 68 (HEV-D68) genomes were detected in two samples after two or three passages in NIID-MDCK-Cs. To further investigate the susceptibility of NIID-MDCK-Cs to adventitious viruses, eight common respiratory viruses were subjected to passages in NIID-MDCK-Cs. The genome copy numbers of seven viruses other than parainfluenza 3 decreased below the limit of detection (LOD) by passage 4. By passaging in NIID-MDCK-Cs, the genome numbers of the input HEV-D68, 1 x 10[SUP]8[/SUP] copies, declined to 10[SUP]2[/SUP] at passage 3 and to under the LOD at passage 4, whereas those of the other six viruses were under the LOD by passage 3. These results implied that during the process of isolating influenza viruses with NIID-MDCK-Cs, contaminating viruses other than parainfluenza 3 can be efficiently removed by passages in NIID-MDCK-Cs. NIID-MDCK-Cs could be a safe substrate for isolating influenza viruses that can be used to develop cell-based influenza vaccine candidate viruses. This article is protected by copyright. All rights reserved.

Keywords: MDCK cells; adventitious virus; cell-based vaccine; influenza vaccine; real-time PCR.
 
Back
Top Bottom